Key facts
- AEBio System’s last known valuation is $4.1M (Sep 2022).
- It has raised $280K; the latest was Seed Round in Jan 2026.
- Notable investors include Lazio Innova.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for AEBio System
- ·The full record, as it builds
Funding rounds
No funding rounds for AEBio System are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AEBio System
Developer of a healthcare platform designed to simplify the monitoring of hospitalized patients. The company's product allows for true passive patient monitoring, customized surveys according to the user's needs, that can be easily accessible to the mobile application, enabling doctors to detect patients' physiological and vital data and can monitor their patients remotely.
- Sector
- Healthcare
- HQ
- Atina, Italy
- Founded
- 2018
- Employees
- 3
- Website
- aebiosystem.com/
- Ownership
- Privately Held (backing)
AEBio System doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AEBio System shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AEBio System in its N-PORT filings yet. We sweep new filings monthly.